Overview

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This US population-based study will explore the incidence of and risks for fracture among adults with and without human immunodeficiency virus (HIV) infection. The objectives are to determine the incidence of fracture among persons with and without HIV infection, compare risk factors for fracture among persons with and without HIV infection, and to examine the associations of antiretroviral (ARV) treatment exposure for incidence and risk of fracture among persons with HIV infection.
Details
Lead Sponsor:
ViiV Healthcare
Collaborator:
GlaxoSmithKline
Treatments:
Abacavir
Anti-Retroviral Agents
Lamivudine
Zidovudine